by Nils Osmar

The information in this article is not intended as, and should not be taken as, medical advice. Interventions like exercising, dietary changes, and taking medications and supplements can have both benefits and side effects, Please consult with a medical professional about any medical concerns.  See full Medical Disclaimer

---

How to read this article

Stem cell biology is one of the most exciting frontiers in longevity science — and one of the most over-hyped corners of the supplement market. This guide tries to thread that needle: take the science seriously without overselling it.

Please note that this article does not cover a stem cell injections; they are large enough topic that they will need their own separate article.

Similarly, this article doesn’t cover the systemic-factor frontier — young plasma and heterochronic parabiosis, GDF11, plasma dilution (the Conboy lab’s work), and therapeutic plasma exchange. That body of research asks a different question — whether the circulating environment can be made more youthful to rejuvenate stem cells indirectly — and it deserves its own separate treatment.

A few words to be aware of:

• Production — making more stem cells, or keeping existing ones from going senescent. Also called “self-renewal.”
• Mobilization — releasing stem cells from a tissue reservoir (usually bone marrow) into the bloodstream.
• Differentiation — getting stem cells to mature into the specific cell type that support healing.

These are not the same thing, and an intervention that does one may or may not help with the others. Mobilizing cells into your blood is not the same as directing them to repair a torn tendon or an arthritic joint. Flooding the bloodstream with stem cells does little for tissue that the bloodstream barely reaches.

Absence of Human Studies

Most of the evidence that I drew on in writing this article is from mice, rats, or cell culture studies. Rodent stem cell biology is informative but not predictive; effective human doses, timing, and even direction of effect can differ.

Within each category, items are ordered roughly from most to least supporting evidence in humans or lab animals. Nothing here is medical advice.

---

1. Fasting

Fasting is the most mechanistically compelling category on this list, largely thanks to the work of Valter Longo’s group at USC.

Prolonged fasting & the fasting-mimicking diet (FMD) — strongest evidence

Longo’s core finding was that prolonged fasting (roughly 48–120 hours in mice) lowers IGF-1 and PKA signaling, which depletes a portion of white blood cells and pushes hematopoietic stem cells (HSCs) into a protected, self-renewing state.

Then, on refeeding, those stem cells activate and regenerate the blood and immune system. In the original 2014 Cell Stem Cell work, prolonged fasting caused roughly a 28% drop in white blood cell count that fully reversed after refeeding, and cycles of fasting restored normal counts even after damage from chemotherapy or aging.

The key point is that stem cell production is not increased during our fast, but in the days following it. So it’s essential to follow a fast by eating a high-quality diet rich in the nutrients needed to support stem cells on every level.

Longo’s version of the fasting-mimicking diet was developed because multi-day water fasts are impractical and risky for many people. It’s a low-calorie, low-protein, low-carbohydrate, high-fat 4–5 day diet engineered to reproduce the same metabolic signals — low glucose and IGF-1, high ketones and IGFBP-1 — without total food deprivation. In mice, FMD cycles drove regeneration not just in the blood system but in the pancreas (β-cell regeneration via transient Ngn3 expression) and elsewhere.

Refeeding is Essential!

The regenerative surge is a refeeding phenomenon. The fast sets up the conditions; the return to food triggers the rebuild. So the days after you break a 5-day FMD are the biologically interesting window — your instinct here is correct.

How long that window stays open in humans is genuinely not well characterized; the rodent data points to a wave over the first days of refeeding rather than a sustained weeks-long state.

Honest limits: the headline regeneration data is in reference to hematopoietic stem cells and largely murine (done in mice). Human FMD trials (e.g., Wei et al.) show the metabolic signatures shift as predicted and some biomarkers of aging improve, but direct measurement of stem cell regeneration in humans is far thinner than the mouse data.

The mechanism is well-supported in preclinical models and consistent with the human biomarker shifts; whether it produces comparable stem cell regeneration in humans, and at what magnitude, is still an open question.

Other fasting patterns — weaker / indirect evidence for stem cells specifically

• Time-restricted eating (e.g., 16:8): strong general metabolic evidence (insulin sensitivity, circadian alignment), but it generally does not reach the depth or duration of IGF-1/PKA suppression that drives the HSC story. Intestinal stem cell benefits from fasting have been shown in mice, but daily TRE is a different stimulus than multi-day fasting.
• Alternate-day / 5:2 fasting: more plausible than TRE for periodically dipping into the relevant signaling, but stem-cell-specific human data is sparse. Most of its evidence base is metabolic and cardiovascular, not regenerative.

Bottom line: the multi-day fast/FMD → refeed cycle is the one with a real mechanistic and (rodent) experimental backbone. Shorter patterns can be beneficial for other reasons but shouldn’t be assumed to support stem cells specifically.

Eating a Ketogenic Diet

One mechanism deserves a spotlight here because it connects fasting, ketogenic eating, and even MCT oil to a specific stem cell compartment. Cheng et al. (Cell, 2019) showed that Lgr5+ intestinal stem cells (ISCs) are distinguished from their differentiated neighbors by high expression of Hmgcs2, the rate-limiting enzyme for making ketone bodies — and that the ketone β-hydroxybutyrate (βOHB) sustains their stemness. Mechanistically, βOHB inhibits class-I HDACs, which reinforces Notch signaling, which in turn instructs ISC self-renewal. The dietary consequence is clean and a little startling: a high-fat ketogenic diet elevated ISC function and post-injury regeneration, while a glucose-heavy diet did the opposite. This is the molecular reason the fasting/refeed and low-glucose story isn’t only about hematopoietic stem cells — it reaches the gut lining through a named signaling axis. (As always, mouse data; but the human relevance of intestinal regeneration is hard to wave away.)

---

2. Exercise

Exercise is the most reliably beneficial intervention for most longevity endpoints, and it does plausibly support several stem cell compartments — though “which exercise, how much, for which stem cells” needs more confirming studies. Based on current evidence, I would say that:

• Endurance / aerobic exercise is the best-supported for muscle satellite cells (muscle stem cells) and for endothelial progenitor cell (EPC) mobilization. Acute aerobic bouts transiently raise circulating CD34+ and EPCs; training improves satellite cell number and function, which matters increasingly with age as these cells decline.
• Resistance training is the strongest stimulus for satellite cell activation and pool expansion specifically — mechanical loading is a direct driver of muscle stem cell proliferation and is central to counteracting age-related muscle loss.
• High-intensity interval training (HIIT) has data pointing toward improved mitochondrial biogenesis and possibly favorable effects on the satellite cell niche, though it’s studied less specifically for stem cell endpoints than for metabolic ones.

Tissue-specific exercises

Exercise is genuinely good for muscle stem cells because muscle is well-vascularized, innervated, and mechanically loaded. The benefit to poorly-vascularized tissue like tendons comes through a different route — mechanical loading of the tendon itself drives local tenocyte/tendon progenitor activity and collagen synthesis — not via systemic stem cell mobilization. (This is exactly why progressive tendon loading protocols work for tendinopathy while “boosting circulating stem cells” does little for a tendon.)

---

3. Diet

These are foods with at least some preclinical signal touching stem cell biology. Treat this as “plausible, mostly rodent/in-vitro, eat them because they’re good food” rather than as targeted therapy.

• Olives & extra-virgin olive oil — the polyphenols (notably hydroxytyrosol and oleuropein) have repeatedly shown pro-osteogenic and anti-senescence effects on mesenchymal stem cells (MSCs) in vitro, plus broad anti-inflammatory niche effects. Among foods on this list, the olive polyphenol MSC data is among the more consistent. (Conveniently, also an FMD-compatible food.)
• Pomegranate — ellagitannins are metabolized by gut bacteria into urolithin A, which has real, repeatedly-demonstrated effects on mitophagy and has shown muscle-function benefits in human trials. The stem cell angle (satellite cell support via improved mitochondrial quality control) is mechanistically reasonable but more inferred than directly measured.
• Shiitake & other medicinal mushrooms — beta-glucans modulate the immune system and there’s some hematopoietic-support signal, but the “mushrooms boost stem cells” claim is mostly extrapolated from immune and animal data. Plausible, not proven.
• Turmeric / curcumin — worth a careful mention precisely because of its asymmetry. Sordillo & Helson (2015) describe curcumin acting differently on cancer stem cells than on normal ones — suppressing the former while being comparatively sparing of (or even supportive to) healthy stem cell populations. That selectivity is the interesting part; it’s the same hormetic, dose-and-context theme that runs through the resveratrol and EGCG discussion below. Bioavailability is famously poor (piperine or lipid formulations help). Treat it as “good anti-inflammatory food with an intriguing stem cell selectivity profile,” not a targeted regenerative agent.
• Grapefruit — Significant evidence of stem cell benefits. See “Naringenin / naringin” under supplements, below.
• Wild blueberries — rich in anthocyanins with strong general anti-inflammatory/antioxidant and neuroprotective data; some rodent work links blueberry polyphenols to improved neural progenitor (hippocampal) function. Good for the niche environment; direct stem cell claims are modest.
• Fermentable fiber & butyrate-producing foods — short-chain fatty acids from gut fermentation, especially butyrate, directly modulate intestinal stem cells. Kaiko et al. (Cell, 2016) showed butyrate has a dose-dependent effect on crypt ISC proliferation (the crypt architecture normally shields stem cells from high butyrate concentrations), and the microbiome more broadly shapes systemic regenerative capacity through inflammation and metabolite signaling. This pairs with the ketone/ISC note above: diet reaches your gut stem cells through more than one metabolic channel. Practical translation: feed the microbiome (fiber, fermented foods), don’t obsess over isolated butyrate supplements.

Two compunds, vanillin and chocolate, deserve special mention.

A note about Vanillin

Vanillin (4-hydroxy-3-methoxybenzaldehyde), the main aromatic compound in vanilla beans, has shown some surprising effects on stem cell resilience under stress. In research on human keratinocyte stem cells — the cells responsible for renewing our skin — vanillin was found to protect against UVB-induced damage. The protective effect acts downstream of MDM2 in the p53 activation pathway, which appears to keep stressed stem cells from prematurely tipping into senescence or apoptosis (Lee et al., 2016, Food and Chemical Toxicology).

A more recent line of work has focused on ortho-vanillin (o-vanillin), a structural isomer of vanillin with senolytic properties — meaning it preferentially clears senescent cells. Co-cultures treated with o-vanillin showed fewer senescent cells and reduced inflammatory cytokines (IL-6 and IL-8), suggesting it improves both the cells and the environment they operate in (Li et al., 2022, Cells).

Vanillin also appears to support bone-forming cells specifically. A 2024 paper in Pharmaceutics demonstrated that vanillin promotes osteoblast differentiation via the BMP2 / Smad1/5/8 / RUNX2 signaling pathway, enhances mineral apposition, and protects osteoblasts from oxidative cell death during bone formation (Yun et al., 2024, Pharmaceutics).

A practical note on dosing: Most of these studies use isolated vanillin at concentrations well above what ordinary food intake provides. Real vanilla bean and high-quality vanilla extract are the richest natural sources; synthetic vanillin (the dominant form in cheap “vanilla flavoring”) is chemically identical but typically used at lower concentrations.

What’s Vanilla without Chocolate?

Recent studies have also suggested that cacao has a rule to play in supporting our stem cells.

The bioactive compound in cacao with the most relevance is (−)-epicatechin, a flavanol concentrated in the unprocessed cocoa bean. Two distinct lines of human research connect it to specific stem and progenitor cell populations.

In a randomized, double-blind, crossover trial published in the Journal of the American College of Cardiology, researchers gave 16 coronary artery disease patients high-flavanol cocoa (375 mg flavanols/day) for 30 days and compared the results to a low-flavanol control period. The high-flavanol intervention produced a 2.2-fold increase in circulating angiogenic cells (CACs), alongside improved flow-mediated dilation and reduced systolic blood pressure (Heiss et al., 2010, JACC).

This is the source of the popular claim that “chocolate doubles your stem cells”. The key caveat is that CACs are not pluripotent stem cells. They are a specialized population dedicated to repairing the inner lining of blood vessels. They’re meaningful for cardiovascular health, but they are not the master cells capable of becoming any tissue type. The study did not show that chocolate boosts your bone marrow stem cells or generates new tissue elsewhere in the body. The headline is true in a narrow sense and misleading in the way most people read it.

A second line of research clarified also that epicatechin activates satellite cells — the resident stem cells of skeletal muscle that drive repair and regeneration after exercise or injury. In an 8-week open-label trial of epicatechin in adults with Becker muscular dystrophy (50 mg twice daily), researchers documented increases in both muscle and plasma follistatin, decreases in myostatin, and elevations in markers of muscle regeneration including Myf5, MyoD, and myogenin (McDonald et al., 2015, Neuromuscular Disorders).

The Heiss study used 375 mg of cocoa flavanols — a dose that requires either real raw cacao powder or a carefully chosen high-flavanol dark chocolate. A typical 30 g serving of supermarket 85% dark chocolate provides roughly 25–50 mg of flavanols, and Dutch-processed (alkalized) cocoa can lose 60–90% of its flavanol content during manufacturing. So while dark chocolate can be a good source, you would have to eat a large amount of it to approximate the amount used in the study, or get similar benefits.

---

4. Supplements

Ordered from strongest to weakest stem-cell-relevant evidence. Doses listed are those commonly cited in the literature/longevity practice, not personalized recommendations.

Best Supported Supplements

Vitamin D3 (with K2) — strong rationale. In human MSCs, Vitamin D receptors are expressed across stem cell populations. Effects are dose- and context-dependent, excess vitamin D in our bloodstream, can have dangers, and more is not necessarily better. 

Zinc — an essential trace mineral that is genuinely required for normal stem cell function, with converging evidence across several stem cell types and independent labs. Zinc drives proliferation, adhesion, migration, and differentiation in mesenchymal and neural progenitor cells (via ERK1/2 and AKT signaling), and is needed to maintain pluripotency in embryonic/induced pluripotent stem cells — partly as a downstream arm of methionine/SAM metabolism. When zinc is low in our bloodstream, stem cell proliferation and differentiation are measurably impaired.

There’s no evidence that loading zinc above sufficiency adds stem cell upside, and excess zinc impairs copper absorption. Typical maintenance: ~8–15 mg/day from diet/supplement; pair with a little copper if supplementing long-term.

Vitamin C (ascorbate) — a genuine, mechanistically specific HSC story that argues for adequacy rather than loading. Agathocleous et al. (Nature, 2017) found that both human and mouse HSCs accumulate unusually high levels of ascorbate, which falls as they differentiate.

The twist is counterintuitive: depleting vitamin C in mice increased HSC frequency — but in the wrong way. Ascorbate is a required cofactor for the Tet dioxygenases, and Tet2 is a tumor-suppressor; starving HSCs of vitamin C lowered Tet2 activity and, in combination with a leukemic mutation (Flt3-ITD), accelerated leukemogenesis — an effect reversed by dietary ascorbate.

So adequate vitamin C isn’t about “boosting” stem cell numbers; it’s about keeping HSCs in a properly regulated, tumor-suppressed state. Unusually for this list, there’s a human-relevant thread too: ascorbate supplementation restored TET activity in the blood cells of deficient leukemia patients and TET2-mutation carriers (Gillberg et al., 2019; Taira et al., 2023). The practical takeaway is the same as zinc and D — correct a deficiency, don’t chase a megadose. The same cofactor role is why ascorbate boosts iPSC reprogramming efficiency in culture.

Naringenin / naringin — stronger than its low profile suggests. Naringin (the glycoside; naringenin is the aglycone) repeatedly promotes proliferation and osteogenic differentiation of mesenchymal stem cells in vitro and in rodents, and shows pro-osteogenic effects even under inflammatory/oxidative stress. Solidly evidenced in cells and animals for the MSC/bone axis; human data is the missing tier. Found naturally in citrus, concentrated in the pith/albedo (grapefruit especially). 

One caution is that both grapefruit and naringenin inhibit CYP3A4 and can markedly raise blood levels of many drugs metabolized by it — including mTOR inhibitors like rapamycin, many statins, and some calcium-channel blockers. This could in theory have either benefits or dangers. they should not be combined with medications, including rapamycin, casually or carelessly. Low dose rapamycin, for example, has clear anti-aging properties; high dose rapamycin can shut down the immune system.

Nicotinamide riboside (NR) / NMN — the strongest preclinical HSC data on this list. The mechanism is specific and well-characterized: by raising NAD+, these compounds enhance mitophagy (clearance of damaged mitochondria), which in expands the progenitor pool without exhausting the stem cells — in mice this improved survival after lethal irradiation by ~80% and sped blood recovery (Vannini et al., Cell Stem Cell 2019).

A second study (Nature Communications 2021) showed NR shifts the aged HSC transcriptome toward a younger state and restores more youthful bone marrow composition, with the effect dependent on continuous supplementation.

Notably, NR also improved engraftment of human CD34+ cells in immunodeficient mice — a step beyond pure rodent data.

Human clinical regenerative data is still thin: NAD+ levels reliably rise with supplementation in humans, but direct evidence that this translates into improved stem cell function or measurable regeneration in people remains limited. The safety profile is good. Typical: 300–500 mg NR or 500–1000 mg NMN.

(Note: Other NAD boosters such as niacin (NA) and nicotinamide (NAM) have not been adequately tested to verify their impact on stem cells. The mechanism suggests that they should have a similar benefit. But both have known drawbacks, including raising blood glucose when taken enlarged doses.)

Senescence-focused supplements

Fisetin — the senolytic with the most consistent in vitro evidence; it targets anti-apoptotic pathways upregulated in senescent cells, and improved age-related cartilage and bone degeneration in mouse models. The evidence tiers are worth stating plainly: strong in vitro, moderate in rodents, and still preliminary in humans — most human data comes from small, short, or uncontrolled studies, with larger clinical trials ongoing.

The logic for stem cells is indirect but real: senescent cells secrete a pro-inflammatory SASP that degrades the stem cell niche; clearing them improves the environment. Common “hit-and-run” protocol: ~500–1000 mg/day for 2–3 consecutive days, repeated periodically. Bioavailability is poor; lipid formulations help. Niche cleanup is plausibly relevant to tendon and joint tissue.

Quercetin — the original named senolytic, and conspicuous by its usual absence from fisetin-only discussions. Zhu et al. (Aging Cell, 2015) — the paper that coined the term “senolytics” — identified quercetin (paired with dasatinib) as selectively clearing senescent cells by disabling their pro-survival defenses. On its own, quercetin is generally considered a weaker standalone senolytic than fisetin, with a narrower target profile; its real significance is as the “Q” in the dasatinib-plus-quercetin combination that carries the strongest human senescent-cell-clearance data to date (see Medications, below). Bioavailability is poor, as with most flavonoids. The same niche-cleanup logic as fisetin applies: less SASP, a less inflamed stem cell environment.

Spermidine — works through autophagy, not as a true senolytic. The foundational work (García-Prat & Muñoz-Cánoves, Nature 2016) showed that basal autophagy is what keeps aged muscle satellite cells in healthy quiescence; when autophagy fails, they tip into irreversible senescence — and restoring autophagy reverses this and rescues their regenerative function. Spermidine is a potent autophagy inducer that reproduces this rescue in aged mice. Sources: wheat germ extract, aged cheese, or ~1–5 mg supplemental. 

Other Supplements of Interest

Astaxanthin — in rodent/in-vitro work, astaxanthin promoted neural progenitor cell (NPC) proliferation via PI3K and MEK signaling and supported stem cell “stemness” markers. Also a potent antioxidant for the niche generally. Reasonable, mostly preclinical.

Oleic acid — A 2022 PNAS study (Kandel et al.) reported that oleic acid is an endogenous ligand of TLX/NR2E1 that triggers hippocampal neurogenesis — TLX is a nuclear receptor governing neural stem cell self-renewal and proliferation, and oleic acid binding flips it from a transcriptional repressor into an activator of cell-cycle and neurogenesis genes. That’s a genuine, specific discovery about neural stem cell biology. 

This finding concerns oleic acid reaching a receptor inside neural stem cells in the brain, which tightly regulates its own fatty acid environment. While it’s plausible that increasing our dietary intake of oleic acid could raise brain oleic acid enough to drive neurogenesis in humans, more research is needed. The study’s own framing points toward future drug-like modulation of TLX, not diet. Note also that oleic acid’s effects in other stem cell compartments are not uniformly positive.

Lithium (low-dose) — one of the better-established pharmacological promoters of adult hippocampal neurogenesis, and a natural companion to the neural-stem-cell thread running through astaxanthin and oleic acid. The mechanism is well-characterized: lithium inhibits GSK-3β, which activates downstream Wnt/β-catenin signaling — a core self-renewal pathway for neural progenitors. The neurogenic effect is robust in rodents, and lithium’s neuroprotective and pro-neurogenic actions are among the more reproducible in the field. (I’ve written separately about low-dose lithium as an inexpensive anti-aging candidate; the stem cell angle is one more reason it earns a place in the conversation.) The usual caveats hold — therapeutic psychiatric lithium and microdose nutritional lithium are wildly different exposures, and the neurogenesis data shouldn’t be read as endorsing high doses.

Omega-3 (EPA/DHA) — niche support via inflammation resolution rather than a direct stem cell driver. In the large human VITAL trial, marine n-3 (1 g/day) plus vitamin D were tested over ~5 years for effects including telomere attrition. Typical longevity dose 2–3 g combined EPA+DHA. Think “improves the environment,” not “mobilizes cells.”

Ergothioneine — a potent cytoprotective antioxidant that accumulates in tissues via a dedicated transporter; associated with healthy aging in epidemiology. Niche-protective rationale; direct stem cell data limited.

Sulforaphane (broccoli sprouts) — the canonical dietary activator of Nrf2, the master transcription factor for cellular antioxidant defense. Nrf2 matters here specifically because it helps maintain HSC redox balance and self-renewal; an HSC pool with disrupted Nrf2 signaling handles oxidative stress poorly. Sulforaphane belongs in the same “keep the niche clean” bin as ergothioneine, but with a better-defined molecular target. Mostly preclinical for stem cells per se; the broader Nrf2/redox rationale is strong, and broccoli sprouts are cheap, real food.

PQQ — promotes mitochondrial biogenesis in cell/animal models; the stem cell link is via mitochondrial quality, indirect.

CoQ10 — mitochondrial support, strongest case in people who are depleted (e.g., statin users or older adults). Indirect for stem cells.

Astragalus — contains cycloastragenol/astragaloside IV, studied for telomerase activation (the TA-65 lineage of products). Telomere maintenance is relevant to stem cell replicative capacity in principle; human regenerative evidence is weak.

Taurine — early but citable. Singh et al. (Science, 2023) reported that circulating taurine declines with age across species, and that restoring it extended healthspan and lifespan in mice while improving multiple tissue-level markers, including some relevant to stem/progenitor function and senescence. It’s a single major paper (with human association data, not yet human intervention data for regeneration), so the right posture is “promising, worth tracking, not established.” Flagged here for completeness in exactly the spirit of the sea buckthorn and fucoidan entries: real signal, awaiting independent confirmation in people.

Sea Buckthorn Berry: Looks Promising, But…

Sea buckthorn (Hippophae rhamnoides) is a bright orange berry with a long history of use in Tibetan, Mongolian, and Chinese traditional medicine. It’s rich in proanthocyanidins, vitamin C, omega fatty acids (including the rare palmitoleic acid), and a range of polyphenols.

In a randomized, double-blind, placebo-controlled crossover trial published in 2019 in Clinical Interventions in Aging, twelve healthy subjects received either 500 mg of a proanthocyanidin-rich sea buckthorn berry extract or placebo. Blood samples drawn at one and two hours after consumption showed rapid increases in three cell populations: CD34+ progenitor cells, endothelial stem cells, and a mesenchymal-type stem cell population — all considered relevant to vascular repair and tissue regeneration (Drapeau et al., 2019, Clinical Interventions in Aging).

A note on funding and conflicts of interest:

The study’s lead author, Christian Drapeau, is the founder of Stemregen, a company that sells the exact sea buckthorn extract used in the study as a stem-cell-mobilization supplement. The second author runs the contract research lab that performed the testing. This isn’t merely industry-adjacent research — the company built around the product is essentially built around this paper. There is no independent replication.

The sample size is small (n=12), the observation window was only two hours, and the study measured acute mobilization of progenitor cells in circulation without documenting what those cells went on to do or whether the effect translated into any clinical benefit.

These concerns don’t mean (to me) that we should dismiss the resulting research out of hand — but they do mean we shouldn’t grant it the same credibility as independent, replicated studies from neutral parties. The honest position with sea buckthorn is this: the finding is biologically plausible and worth tracking, but it has not yet been confirmed by anyone without a financial stake in the conclusions.

Fucoidan

Fucoidan (brown seaweed) / AFA blue-green algae / StemRegen-type blends — this category has some genuine human signal that’s worth stating fairly. A double-blind crossover study of an Aphanizomenon flos-aquae (AFA) extract in 12 healthy subjects reported a transient ~18–25% increase in circulating CD34+ cells peaking about an hour after consumption, via an L-selectin (CD62L) ligand mechanism that down-regulates CXCR4 and releases marrow cells. Fucoidan similarly mobilizes CD34+ cells.

But two big asterisks: (1) much of this research traces back to people affiliated with the products, and independent replication is thin; and (2) — the recurring theme — transient mobilization into the blood is not targeted repair. Having more CD34+ cells circulating for an hour does not necessarily mean they home to a specific injured part of the body.

EGCG and Resveratrol – Possible Dangers vs. Benefits

Two popular polyphenols — green tea EGCG and resveratrol — appear to have both potential benefits and potential drawbacks, depending on the circumstances and the dose.

EGCG has been shown to strongly enhance their osteogenic (bone) differentiation and improve overall stem cell capabilities. But it has also been shown to inhibit the proliferation and differentiation of normal mesenchymal stem cells in culture. Both effects are related to dose, with no clear guidance as to optimal human dosing.

Resveratrol shows evidence of being beneficial for healthy stem cells and has anti-cancer effects (in relation to some cancers). Butt its effects are dose-dependent. High concentrations of resveratrol have been found to suppress and damage stem cell growth.

Some primary evidence for this came from Peltz et al. (2012), who examined resveratrol’s effects on human mesenchymal stem cells at concentrations from 0.1 to 10 µM. At 0.1 µM it promoted self-renewal by inhibiting cellular senescence, whereas at 5 µM or above it inhibited self-renewal by increasing the senescence rate, cell doubling time, and S-phase cell cycle arrest.

At the intermediate 1 µM dose, the effect on self-renewal was short-term but became inhibitory after long-term exposure, again with increased senescence. In light of the uncertainty, I would question the inclusion of these two compounds in protocols designed to support stem cells. I am not taking either of them currently.

What dose of resveratrol is safe?

The studies were in vitro and do not provide this information.

Sources: Potential Adverse Effects of Resveratrol: A Literature Review and Resveratrol: A Double-Edged Sword

Are Antioxidants Supplements Safe (for Stem Cells)?

The answer again suggests that it depends on the supplement and dose.

A Russian group (Borodkina/Burova lab) published two papers showing that high but non-cytotoxic antioxidant doses — including resveratrol — induce a reversible block of proliferation in quiescent MSCs but, when applied to proliferating cells, can cause irreversible cell cycle arrest, DNA strand-break accumulation, and DNA-damage-response activation, ultimately triggering stress-induced premature senescence. Their follow-up traced the mechanism to endoplasmic reticulum stress and the unfolded protein response, with upregulation of genes tied to stress, DNA damage, and cellular senescence. See study.

From the study:

In our previous study, we found that high doses of several substances with antioxidant capacities (Tempol, resveratrol, diphenyleneiodonium) can cause genotoxic stress and induce premature senescence in the human mesenchymal stem cells (MSCs).

Here, using whole-transcriptome analysis, we revealed the signs of endoplasmic reticulum stress and unfolded protein response (UPR) in MSCs stressed with Tempol and resveratrol. In addition, we found the upregulation of genes, coding the UPR downstream target APC/C, and E3 ubiquitin ligase that regulate the stability of cell cycle proteins. We performed the molecular analysis, which further confirmed the untimely degradation of APC/C targets (cyclin A, geminin, and Emi1) in MSCs treated with antioxidants. Human fibroblasts responded to antioxidant applications similarly. We conclude that endoplasmic reticulum stress and impaired DNA synthesis regulation can be considered as potential triggers of cell damage and premature senescence stimulated by high-dose antioxidant treatments.

---

5. Medications (worth understanding, not casually self-prescribing)

These appear in the regenerative literature but are pharmaceuticals with real risks; included for completeness and accuracy.

Dasatinib + Quercetin (D+Q) — the strongest human senolytic evidence that currently exists. Dasatinib is an FDA-approved tyrosine-kinase inhibitor (for leukemia); quercetin is the dietary flavonoid above. Together they were the first senolytic combination tested in people. Hickson et al. (EBioMedicine, 2019) reported that a short “hit-and-run” course measurably reduced senescent-cell burden in human adipose tissue within 11 days — fewer p16- and p21-expressing cells, less senescence-associated β-galactosidase activity, fewer tissue macrophages, and lower circulating SASP factors (IL-6, MMPs) — an effect that outlasted the drugs’ sub-11-hour half-lives.

A separate first-in-human pilot in idiopathic pulmonary fibrosis (Justice et al., 2019) reported improved physical function. This matters for the stem cell story because the same trial program is explicitly examining whether clearing senescent cells restores mesenchymal stem cell functionality. The honest framing: this is the rare senolytic with direct human senescent-cell-clearance data — but dasatinib is a serious prescription drug with real cardiovascular and hematologic risks, firmly in the “understand it, don’t DIY it” category. (Fisetin and quercetin are the over-the-counter cousins people actually reach for; D+Q is the one with the human biopsy data.)

Clobetasol / certain glucocorticoids — Hedgehog (Smo) agonism. A 2019 study found clobetasol (and fluocinonide, fluticasone) act as Smoothened agonists, activating canonical Sonic Hedgehog signaling and increasing proliferation/clonal expansion of adult neural stem cells — notably, most other glucocorticoids (prednisone, dexamethasone, corticosterone) did not do this. This builds on earlier high-profile work (Najm et al., 2015) where miconazole and clobetasol promoted oligodendrocyte precursor differentiation and remyelination in mouse models of MS.

Important framing: this is niche-specific (neural/oligodendrocyte lineages via Hedgehog), not a general systemic stem cell tonic. And clobetasol is a super-high-potency topical steroid with significant systemic effects when absorbed (HPA-axis suppression, skin atrophy, and more).

The science is fascinating, but treating it as a DIY stem cell supplement would be a mistake. It belongs in the “interesting drug-repurposing research” bin, firmly under medical supervision.

Miconazole — same Najm et al. remyelination story; an antifungal that promoted OPC differentiation in mice. Same caveat: specific lineage, mouse data, not a general protocol.

---

6. Sleep, Light and Darkness

Before starting on supplements, I would take a moment to make sure that you’re asleep and circadian rhythms have been taken into consideration.

Hematopoietic stem cell behavior is directly governed by your day/night clock, not loosely associated with it. Work from Tsvee Lapidot’s group (and others) has mapped a daily two-phase cycle: at light onset (morning), a pulse of bone marrow norepinephrine and TNF drives HSC differentiation and egress into the bloodstream to replenish circulating blood and immune cells; at darkness onset (night), rising bone marrow melatonin does the opposite — it reprograms HSCs back toward an undifferentiated, primitive state, renewing the stem cell reservoir and boosting their long-term repopulation potential. MSCs in the marrow show the same rhythm, with peak proliferation and osteogenic potential at night.

The short version is, to support our stem cell production directly, we should all be optimizing our sleep, and getting early morning light exposure.

It’s worth noting also that shift work, chronic short sleep, late-night light exposure, jet lag — measurably degrades bone marrow hematopoietic function in animal models and is associated with worse outcomes in humans. Consistent, sufficient, dark-aligned sleep isn’t just “good for recovery” in a vague sense; it’s when a meaningful part of your stem cell maintenance actually happens. Of everything on this list, this is the cheapest high-quality intervention available.

Practical translation: protect sleep duration and regularity, keep nights genuinely dark, and respect the light/dark cycle. This is the lifestyle backbone that the supplement section sits on top of.

Melatonin (as a supplement)

Given melatonin’s central role in the nighttime “reservoir renewal” phase, supplemental melatonin is a reasonable mechanistic candidate, and rodent/in-vitro data support it: melatonin protects bone marrow MSCs against oxidative (hydrogen-peroxide) damage and supports the HSC renewal program. Human regenerative data is thin, and dosing is genuinely uncertain — higher is not better, and very high doses can blunt the body’s own rhythm.

A key nuance: exogenous melatonin doesn’t just promote sleep, it can shift circadian phase depending on when it’s taken (earlier or later than your natural melatonin onset), so timing matters as much as dose. Most circadian-support use is low-dose (~0.3–1 mg) timed to evening, far below the 5–10 mg often sold. 

Melatonin precursors (tryptophan / 5-HTP)

L-tryptophan has a decades-deep human sleep literature: a 2021 systematic review and meta-analysis found doses ≥1 g shorten wake-after-sleep-onset and improve sleep quality, and older EEG work specifically links it to increased slow-wave (deep) sleep and reduced sleep latency.

Mechanistically this is a two-pronged effect — raising serotonin (itself sleep-promoting) plus enabling gradual endogenous melatonin — rather than the single receptor-flooding bolus of exogenous melatonin, which may be why some individuals who react poorly to melatonin tolerate precursors well.

Practical notes: tryptophan competes with other large neutral amino acids for transport into the brain, so it’s typically taken away from a high-protein meal (sometimes with a little carbohydrate) to improve uptake.

There have been no studies specifically into the use of tryptophan or 5-HTP as stem cell enhancers. They belong here only as tools for the genuine lever: consistent, deep, well-timed sleep.

Hyperbaric oxygen therapy (HBOT)

HBOT stands out on this list for having stronger human evidence than most supplements. In humans, a course of HBOT (e.g., 20 sessions at 2.0 ATA on 100% oxygen) produced roughly an eightfold increase in circulating CD34+ stem/progenitor cells, via a nitric-oxide-dependent mobilization mechanism from the bone marrow.

Even much milder “hyperbaric air” protocols roughly doubled-to-tripled circulating stem progenitor cells with durability out to 72 hours post-treatment. Separately, a prospective trial in healthy older adults (Hachmo et al.) reported that an HBOT protocol increased telomere length and reduced senescent cell fractions in circulating immune cells.

The caveats are familiar by now: (1) mobilization into the blood is not the same as targeted repair of a specific tissue; (2) HBOT is expensive, time-intensive, and not without risk (barotrauma, oxygen toxicity at higher pressures), so it sits in a different practical bracket than diet and sleep; and (3) much of the anti-aging HBOT work comes from a single research group (Efrati’s team at Shamir Medical Center) and awaits broad independent replication.

With these caveats noted, HBOT as a human-evidenced mobilizer, is genuinely better documented than the marketed algae/fucoidan products.

Photobimodulation

If HBOT is the high-pressure end of “energizing the niche,” photobiomodulation is its low-tech cousin. Red and near-infrared light (typically ~630–850 nm) is absorbed by mitochondrial cytochrome c oxidase, transiently boosting ATP production and redox signaling, and a real (if heterogeneous) literature shows low-level light stimulating mesenchymal stem cell proliferation and function in vitro and in animal models. The honest framing mirrors HBOT’s: the mechanism is plausible, the in-vitro signal is consistent, but protocols (wavelength, dose, timing) are all over the map and human regenerative endpoints are thin — and, as always, stimulating cells in a dish is not the same as targeted repair in a person. It earns a mention as an accessible, low-risk niche-support tool, not a proven stem cell therapy.

Low Oxygen interventions

A conceptual footnote worth making explicit: most stem cell niches are natively low-oxygen. The undisturbed bone marrow HSC niche is hypoxic, and HIF-1α signaling helps keep stem cells quiescent and protected. This is the conceptual mirror of the HBOT section — and a useful caution against assuming “more oxygen is always better” for stem cells. Intermittent hypoxic protocols (and altitude-style training) can mobilize CD34+/endothelial progenitor cells, but the relevant point for this guide is that the niche’s baseline hypoxia is a feature, not a deficiency to be corrected. File this under “understand the niche,” alongside the sleep and circadian material.

---

7. What may harm stem cells

A guide like this is incomplete without the other side of the ledger:

• UV / excess sun exposure — UV radiation damages epidermal and melanocyte stem cells (a driver of skin aging and skin cancer), and depletes the relevant progenitor pools. Sensible sun protection is a pro-stem-cell move. The anti-UV radiation benefits of astaxanthin are the main reason I included it in this article.
• Chronic NSAID use during active tissue healing — NSAIDs blunt the inflammatory/prostaglandin signaling that early tissue repair (including tendon and bone) actually requires, and can impair satellite cell and tendon progenitor activity. Short-term symptomatic use is one thing; routine use during active healing works against you.
• Chronic hyperglycemia / high IGF-1 / high insulin — the opposite of the fasting signal. Sustained progrowth signaling pushes stem cells toward exhaustion and senescence over time; this is much of why caloric restriction and fasting help.
• Smoking, chronic alcohol, chronic psychological stress, sleep deprivation — all degrade the stem cell niche through oxidative stress, inflammation, and cortisol dysregulation.
• Iron overload — excess iron drives oxidative stress (Fenton chemistry) that measurably damages HSCs and impairs hematopoietic function. Relevant to the over-supplementing crowd: iron is one to correct only if you’re actually deficient, not to take prophylactically. Folate / B12 deficiency — the deficiency-side bookend to the zinc and vitamin C entries. Both are required for the DNA synthesis that hematopoiesis depends on; lacking them causes megaloblastic failure of blood cell production. A reminder that for stem cells, correcting a deficiency is often the highest-yield move — in both directions.
• Chronic systemic inflammation generally — an inflamed niche is a hostile niche; SASP from accumulated senescent cells is a specific, targetable version of this (see fisetin, above).
• As noted above, large doses of resveratrol have been shown to be (potentially) harmful.

---

On the quality of the evidence

The interventions with the best claim are: the fast/refeed cycle (strong mechanism, real rodent data, plausible human signal), exercise and mechanical loading (well-evidenced, tissue-appropriate), consistent dark-aligned sleep (a direct, free lever on the daily HSC maintenance cycle), avoiding nutrient deficiency (zinc, vitamin D), and keeping the niche clean and uninflamed (sun sense, avoiding NSAIDs mid-healing, managing senescence).

HBOT is the rare intervention-tier item with solid human mobilization data, at the cost of money and access. The mobilizer supplements are the ones where the gap between the marketing and the evidence is widest.

Bibliography

Selected References

Primary studies and key reviews underlying the claims above, grouped by topic. Most are preclinical (cell or animal) unless noted; this is a selected, not exhaustive, list. Where a finding is in mice or in vitro, that limitation applies as discussed in the relevant section.

All entries below were verified against PubMed and publisher records. Corrections from the prior draft are noted at the end.

Fasting & the fasting-mimicking diet

Cheng C-W, Adams GB, Perin L, et al. Prolonged fasting reduces IGF-1/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression. Cell Stem Cell. 2014;14(6):810–823. doi:10.1016/j.stem.2014.04.014

Brandhorst S, Choi IY, Wei M, et al. A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan. Cell Metabolism. 2015;22(1):86–99. doi:10.1016/j.cmet.2015.05.012

Cheng C-W, Villani V, Buono R, et al. Fasting-mimicking diet promotes Ngn3-driven β-cell regeneration to reverse diabetes. Cell. 2017;168(5):775–788.e12. doi:10.1016/j.cell.2017.01.040

Sleep, circadian rhythm & melatonin

Golan K, Kollet O, Markus RP, Lapidot T. Daily light and darkness onset and circadian rhythms metabolically synchronize hematopoietic stem cell differentiation and maintenance: the role of bone marrow norepinephrine, tumor necrosis factor, and melatonin cycles. Experimental Hematology. 2019;78:1–10. doi:10.1016/j.exphem.2019.08.008

García-García A, Korn C, García-Fernández M, et al. Dual cholinergic signals regulate daily migration of hematopoietic stem cells and leukocytes. Blood. 2019;133(3):224–236. doi:10.1182/blood-2018-08-867648

Zhdanova IV, Wurtman RJ, Regan MM, et al. Melatonin treatment for age-related insomnia. J Clin Endocrinol Metab. 2001;86(10):4727–4730. doi:10.1210/jcem.86.10.7901 (physiological-dose melatonin)

Melatonin precursors (tryptophan / 5-HTP)

Sutanto CN, Loh WW, Kim JE. The impact of tryptophan supplementation on sleep quality: a systematic review, meta-analysis, and meta-regression. Nutrition Reviews. 2022;80(2):306–316. doi:10.1093/nutrit/nuab027

Hyperbaric oxygen therapy (HBOT)

Thom SR, Bhopale VM, Velazquez OC, et al. Stem cell mobilization by hyperbaric oxygen. Am J Physiol Heart Circ Physiol. 2006;290(4):H1378–H1386. doi:10.1152/ajpheart.00888.2005

Hachmo Y, Hadanny A, Abu Hamed R, et al. Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells: a prospective trial. Aging (Albany NY). 2020;12(22):22445–22456. doi:10.18632/aging.202188

Shandley S, Wolf EG, Schubert-Kappan CM, et al. Increased circulating stem cells and better cognitive performance in traumatic brain injury subjects following hyperbaric oxygen therapy. Undersea Hyperb Med. 2017;44(3):257–269. doi:10.22462/5.6.2017.6

Supplements — NAD precursors (NR/NMN)

Vannini N, Campos V, Girotra M, et al. The NAD-booster nicotinamide riboside potently stimulates hematopoiesis through increased mitochondrial clearance. Cell Stem Cell. 2019;24(3):405–418.e7. doi:10.1016/j.stem.2019.02.012

Sun X, Cao B, Naval-Sanchez M, et al. Nicotinamide riboside attenuates age-associated metabolic and functional changes in hematopoietic stem cells. Nature Communications. 2021;12:2665. doi:10.1038/s41467-021-22863-0

Supplements — vitamin D, zinc, naringin, spermidine, fisetin, astaxanthin

Zhou S, LeBoff MS, Glowacki J. Vitamin D metabolism and action in human bone marrow stromal cells. Endocrinology. 2010;151(1):14–22. doi:10.1210/en.2009-0969 (MSC senescence / multipotency)

Moon M-Y, Kim HJ, Choi BY, et al. Zinc promotes adipose-derived mesenchymal stem cell proliferation and differentiation towards a neuronal fate. Stem Cells International. 2018;2018:5736535. doi:10.1155/2018/5736535

Yin L, Cheng W, Qin Z, et al. Effects of naringin on proliferation and osteogenic differentiation of human periodontal ligament stem cells in vitro and in vivo. Stem Cells International. 2015;2015:758706. doi:10.1155/2015/758706

Wang H, Li C, Li J, et al. Naringin enhances osteogenic differentiation through the activation of ERK signaling in human bone marrow mesenchymal stem cells. Iran J Basic Med Sci. 2017;20(4):408–414. doi:10.22038/ijbms.2017.8582 (naringin, MSC osteogenesis)

García-Prat L, Martínez-Vicente M, Perdiguero E, et al. Autophagy maintains stemness by preventing senescence. Nature. 2016;529(7584):37–42. doi:10.1038/nature16187 (spermidine / satellite cell autophagy basis)

Zhang Q, Han W, Wu R, et al. Spermidine-eIF5A axis is essential for muscle stem cell activation via translational control. Cell Discovery. 2024;10:94. doi:10.1038/s41421-024-00712-w

Yousefzadeh MJ, Zhu Y, McGowan SJ, et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. 2018;36:18–28. doi:10.1016/j.ebiom.2018.09.015

Kim JH, Nam SW, Kim BW, et al. Astaxanthin improves stem cell potency via an increase in the proliferation of neural progenitor cells. Int J Mol Sci. 2010;11(12):5109–5119. doi:10.3390/ijms11125109 (astaxanthin / NPC; PI3K and MEK signaling)

Oleic acid & neural stem cells

Kandel P, Semerci F, Mishra R, et al. Oleic acid is an endogenous ligand of TLX/NR2E1 that triggers hippocampal neurogenesis. Proc Natl Acad Sci USA. 2022;119(13):e2023784119. doi:10.1073/pnas.2023784119

Shi Y. Oleic acid regulates hippocampal neurogenesis as a TLX ligand (commentary). Proc Natl Acad Sci USA. 2022;119(15):e2203038119. doi:10.1073/pnas.2203038119

Polyphenols — cancer vs. healthy stem cells, and dose-dependence (hormesis)

Sordillo PP, Helson L. Curcumin and cancer stem cells: curcumin has asymmetrical effects on cancer and normal stem cells. Anticancer Research. 2015;35(2):599–614.

Peng L, Jiang D. Resveratrol eliminates cancer stem cells of osteosarcoma by STAT3 pathway inhibition. PLOS One. 2018;13(10):e0205918. doi:10.1371/journal.pone.0205918

Peltz L, Gomez J, Marquez M, et al. Resveratrol exerts dosage and duration dependent effect on human mesenchymal stem cell development. PLOS One. 2012;7(5):e37162. doi:10.1371/journal.pone.0037162 (biphasic/hormetic effect on healthy MSCs)

Dai Z, Li Y, Quarles LD, et al. Resveratrol enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via ER-dependent ERK1/2 activation. Phytomedicine. 2007;14(12):806–814. doi:10.1016/j.phymed.2007.04.003

Avocado/soybean unsaponifiables (ASU) & chondrogenesis

Hashemibeni B, Izadi MA, Valiani A, et al. Investigation and comparison of the effect of TGF-β3, kartogenin and avocado/soybean unsaponifiables on the in-vitro and in-vivo chondrogenesis of human adipose-derived stem cells on fibrin scaffold. Iran J Pharm Res. 2021;20(3):368–380. doi:10.22037/ijpr.2020.114420.14851

Marketed mobilizers (AFA / fucoidan)

Jensen GS, Hart AN, Zaske LAM, et al. Mobilization of human CD34+CD133+ and CD34+CD133− stem cells in vivo by consumption of an extract from Aphanizomenon flos-aquae—related to modulation of CXCR4 expression by an L-selectin ligand? Cardiovasc Revasc Med. 2007;8(3):189–202. doi:10.1016/j.carrev.2007.03.004

Drug-repurposing (Hedgehog/Smo agonists)

Vicario N, Bernstock JD, Spitale FM, et al. Clobetasol modulates adult neural stem cell growth via canonical Hedgehog pathway activation. Int J Mol Sci. 2019;20(8):1991. doi:10.3390/ijms20081991

Najm FJ, Madhavan M, Zaremba A, et al. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo. Nature. 2015;522(7555):216–220. doi:10.1038/nature14335 (miconazole, clobetasol / OPC)

---

Donations welcome

• Donations make this website possible.
• To donate using Buymeacoffee, please click here.

More from Nils Osmar

• Anti-Aging Youtube channel Pathways to Longevity
• Anti-Aging Facebook group: Anti-Aging and Life Extension
• Rekindle School classes in Seattle: Rekindl.e School
• My personal website: My articles, art and more: Nilsosmar.com
• Exploring possible consciousness in Claude.AI and other LLMs: AI Consciousness
• Donations make this website possible. To donate using Buymeacoffee, please click here